Tuberculosis is one of the leading causes of death due to infectious disease. Its treatment lasts for several months (with side effects), which makes adherence a major challenge. The current ‘directly ...
DelveInsight's tuberculosis pipeline report depicts a robust space with 30+ active players working to develop 35+ pipeline therapies for tuberculosis treatment. Key tuberculosis companies such as ...
For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the ...
Tuberculosis, a contagious bacterial disease, is caused by Mycobacterium tuberculosis. It affects the lungs and spreads through the air, especially when an affected person sneezes, coughs or spits.
In an interview with HT Lifestyle, Dr Pratibha Dogra, Senior Consultant - Pulmonology at Marengo Asia Hospital in Gurugram, explained, “Pulmonary tuberculosis is a highly contagious disease that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results